HomeNewsBusinessWorst of COVID-19 over for TCS, recovery in sight: CFO V Ramakrishnan

Worst of COVID-19 over for TCS, recovery in sight: CFO V Ramakrishnan

The confidence, Ramakrishnan says, comes from the strong order pipeline, heightened conversation with customers and also the kind of opportunities they are seeing.

July 13, 2020 / 07:06 IST
Story continues below Advertisement

TCS will selectively open lateral hiring and will go ahead with fresher hiring in geographies such as the US though the numbers are small at the back of the pandemic.

This comes as a surprise as companies are freezing hiring to cut costs. This is a move TCS reversed in the first quarter. Announcing the results for the March quarter, the company said that, while the company would honour all the offers, there would be a freeze on lateral hiring at the back of COVID-19.

Story continues below Advertisement

Has the situation changed for the better? V Ramakrishnan, Chief Financial Officer, seems to think so. The worst is over, at least for TCS, he said during a recent interaction with Moneycontrol.

As per CEO Rajesh Gopinathan, the company has better visibility now and expects recovery from the third quarter onwards.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show